Mile High Labs Opens State-Of-The-Art Facility

The CBD company recently opened its new 400,000-square-foot facility in Broomfield, CO. Photo by Mile High Labs

Mile High Labs recently opened its new 400,000-square-foot facility in Broomfield, CO. The large-scale CBD ingredient and product manufacturer purchased and closed on the facility on June 19, and the transaction included the land, labs, building, and ready-to-use finished products manufacturing equipment. The space was previously a pharmaceutical facility. The company produces private label products including tinctures, capsules, tablets, topicals, and gummies, and the facility includes equipment and infrastructure for research and development, quality assurance, bottling, filling, packing, warehousing, labeling, shipping, and compliance monitoring. “In light of recent legislative developments, the demand for our products has increased considerably,” says Stephen Mueller, chief technology officer and founder of Mile High Labs. “And it’s not just a domestic phenomenon. CBD is a global product and we serve a global customer base. This large-scale production facility will ensure we have the capacity to provide high quality, consistent CBD to every customer, large or small.”  


Purdue Receives USDA Grant To Study Organic Hemp Production

QAI Offers USDA Organic Certification For Hemp Crops And Products


The most comprehensive and up-to-date information relating to the pandemic.

All the day's coronavirus-related news and additional stories for small businesses.

Arthritis Foundation Releases First CBD Guidelines for Adults with Arthritis

Suggested Articles

Valmont’s second boutique opened its doors on September 1.

TruSculpt flex is cleared and approved by Health Canada for the strengthening of abdominal tone and firming of the abdominal muscles.

The partnership will help market and distribute Neauvia North America's Plasma IQ.